Search

everythinglearnresearchcommunity

for

Search:↓

Alpha-blockers are recommended first for recent CP/CPPS, while antimicrobials are not advised for long-term cases.

Neuropathic pain is common in long COVID patients, especially those with depression or severe COVID-19.

Photobiomodulation therapy can reduce pain and inflammation and help heal tissues, but more research is needed to improve its effectiveness and safety.

Improving topical drug delivery involves overcoming skin barriers and using personalized dosing to enhance effectiveness.

Tropical herbs are better for hair care than synthetic additives.

Rural South Florida faces challenges in accessing dermatologic care, with many patients not attending specialist appointments.

The guideline provides healthcare professionals in South Africa with instructions for comprehensive, multidisciplinary gender-affirming care, including HIV prevention and treatment for transgender and gender diverse individuals.

Yes, smoking damages your skin.

The chapter explains common scalp conditions, including infections, infestations, and tumors.

Collaboration and innovation are key to developing effective, safe hair loss treatments.

Skin-on-a-chip devices better mimic human skin for research.

Chimp Haven uses a special system to check and improve the well-being of their chimpanzees, which could help other animal sanctuaries too.

Tinea capitis in adults, especially postmenopausal Black women, needs prompt treatment with oral antifungals to avoid scarring.

The CNC® prosthetic system improved body image in breast cancer patients with hair loss from chemotherapy but did not significantly change their psychological wellbeing.

In late pregnancy, allopregnanolone reduces stress responses in rats by affecting brain chemicals.

Mutations in the PADI3 gene are linked to a higher risk of scarring hair loss in women of African descent.

Type 2 diabetes, bacterial scalp infections, and tight hairstyles like braids and weaves are linked to a higher risk of a scarring hair loss condition in African American women.

No single treatment is clearly effective for central serous chorioretinopathy.

Some African American women's central scalp hair loss is linked to genetics and past fungal scalp infections, with more research needed on other causes.

CCCA is a hair loss type affecting African women, possibly caused by grooming and chemicals, with various treatments and needing more research.

CCCA is a scarring hair loss condition mainly in African descent women, possibly caused by genetics and hairstyling, treated with gentle hair care and medications.

Researchers found a white halo around hair in most patients with a specific type of hair loss, which helps in early diagnosis and treatment.

Certain mouse strains develop a skin condition similar to a human hair loss disease due to genetic defects.

Testosterone needs to be converted to DHT to reduce stress response in male rats.

DHEA treatment helps grow pubic hair and boosts mood in girls with adrenal issues.

A scale was made to measure hair loss severity in African American women.

Hair breakage may be an early sign of a hair loss condition called CCCA in African American women.

The document concludes that better treatments for CCCA are needed and more research is required to understand its causes related to hairstyling and genetics.

Buserelin safely and effectively suppresses early puberty, potentially improving final height.

Diagnose and manage CCCA with thorough history, exams, and labs; treat with anti-inflammatory agents, stress reduction, and stopping harmful hair practices.